GLOBAL IRON CHELATION DRUG MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Feb 2019 120

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 µg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.

Scope of the Report:
North America is the largest consumption region of Iron Chelation Drug, with a consumption value market share nearly 31.03% in 2016. Europe is the second largest consumption region of Iron Chelation Drug, enjoying consumption value market share nearly 25.30% in 2016. Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Iron Chelation Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Iron Chelation Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Apotex Inc. (Canada)
- Cipla (India)
- Novartis (Switzerland)
- Sun Pharma (India)
- Natco Pharma (India)

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Deferoxamine
- Deferiprone
- Deferasirox

Market Segment by Applications, can be divided into
- Transfusional Iron Overload
- NTDT Caused Iron Overload

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iron Chelation Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Iron Chelation Drug, with price, sales, revenue and global market share of Iron Chelation Drug in 2017 and 2018.
Chapter 3, the Iron Chelation Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iron Chelation Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Iron Chelation Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Iron Chelation Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Nov 19)

Scope of the Report: The global Hemoglobinopathies market is valued at xx million USD in 2018 and is expected to reach xx million USD...

(Nov 19)

Scope of the Report: The worldwide market for Nutritional Supplements is expected to grow at a CAGR of roughly xx% over the next five...

(Nov 19)

Scope of the Report: The global Pet Obesity Management market is valued at xx million USD in 2018 and is expected to reach xx million...

(Nov 19)

Scope of the Report: The worldwide market for Formoterol Fumarate is expected to grow at a CAGR of roughly xx% over the next five yea...

(Nov 19)

Scope of the Report: The worldwide market for Beclomethasone Dipropionate is expected to grow at a CAGR of roughly xx% over the next ...

(Nov 19)

Scope of the Report: The global Antiaging Products and Services market is valued at xx million USD in 2018 and is expected to reach x...

GLOBAL IRON CHELATION DRUG MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy